Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceutical    crawled time : 10:00    save search
MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
Published: 2023-10-25 (Crawled : 10:00) - biospace.com/
MOR | News | $18.07 0.17% 0.17% 130K twitter stocktwits trandingview |
Health Technology
 | | O: 3.05% H: 3.24% C: 0.85%
sales financial monjuvi
Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities
Published: 2023-10-19 (Crawled : 10:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
 | | O: -0.75% H: 1.01% C: -0.8%
biktarvy treatment hiv
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
Published: 2023-10-10 (Crawled : 10:00) - biospace.com/
VTRS | News A | $11.55 1.67% 1.65% 7.2M twitter stocktwits trandingview |
Health Technology
 | | O: 0.93% H: 0.1% C: -1.33%
duphaston acquire agreement
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 02, 2023
Published: 2023-08-02 (Crawled : 10:00) - biospace.com/
ACAD | News | $16.57 -1.02% -1.03% 1.3M twitter stocktwits trandingview |
Health Technology
 | | O: -0.66% H: 2.71% C: 1.57%
nasdaq pharmaceuticals grants
Takeda Reports Strong First Quarter FY2023 Results, Driven by Growth & Launch Products
Published: 2023-07-27 (Crawled : 10:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K twitter stocktwits trandingview |
Health Technology
 | | O: 0.97% H: 1.35% C: 0.06%
fy2023 growth
Taro Provides Results for the Quarter Ended June 30, 2023
Published: 2023-07-27 (Crawled : 10:00) - biospace.com/
TARO | $42.2 -0.07% 0.0% 19K twitter stocktwits trandingview |
Health Technology
 | | O: 0.27% H: 0.54% C: -0.16%
results
Protagonist Therapeutics Announces Positive Topline Results with JNJ-2113, the First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis
Published: 2023-07-04 (Crawled : 10:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
PTGX S | $25.68 -4.36% -4.56% 330K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
jnj-2113 psoriasis positive il-23 topline therapeutics results
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Published: 2023-06-29 (Crawled : 10:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: -1.86% H: 0.0% C: 0.0%
drug institute research sanofi
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention Bio, Inc.
Published: 2023-04-26 (Crawled : 10:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
 | | O: -1.46% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: 0.53% H: 0.0% C: 0.0%
PRVB | $24.98 0.08% 9.1M twitter stocktwits trandingview |
Health Technology
 | | O: 2.52% H: 0.0% C: 0.0%
acquisition
Addex Regains Nasdaq Listing Compliance - February 09, 2023
Published: 2023-02-09 (Crawled : 10:00) - biospace.com/
ADXN | $18.74 -10.32% 12K twitter stocktwits trandingview |
Health Technology
 | | O: 3.68% H: 13.48% C: 6.07%
nasdaq
Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3
Published: 2023-02-02 (Crawled : 10:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K twitter stocktwits trandingview |
Health Technology
 | | O: 0.76% H: 0.12% C: -1.44%
fy2022 growth pipeline
Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan
Published: 2022-12-13 (Crawled : 10:00) - biospace.com/
VTRS | News A | $11.55 1.67% 1.65% 7.2M twitter stocktwits trandingview |
Health Technology
 | | O: 1.89% H: 0.88% C: -0.09%
CALT | $18.5 1.65% 1.62% 1.5K twitter stocktwits trandingview |
Health Technology
 | | O: 4.72% H: 1.19% C: -0.88%
nephropathy japan license therapeutics agreement therapy
MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
Published: 2022-12-13 (Crawled : 10:00) - biospace.com/
IFF 4 | $85.14 -0.34% 0.0% 1.1M twitter stocktwits trandingview |
Consumer Non-Durables
 | | O: 3.42% H: 0.36% C: -2.3%
health program diabetes milestone
Mirum Pharmaceuticals’ LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and Older
Published: 2022-12-13 (Crawled : 10:00) - biospace.com/
MIRM | $24.0 -1.72% -1.75% 320K twitter stocktwits trandingview |
Health Technology
 | | O: 3.79% H: 0.52% C: -6.15%
treatment pruritus livmarli approved
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Published: 2022-11-22 (Crawled : 10:00) - biospace.com/
ALC | $79.57 -1.47% 0.0% 850K twitter stocktwits trandingview |
Health Technology
 | | O: 1.79% H: 0.07% C: -0.33%
KALA | $6.5661 4.24% 1.1K twitter stocktwits trandingview |
Health Technology
 | | O: 0.34% H: 0.5% C: -2.01%
acquisition
Verona Pharma strengthens commercialization leadership team
Published: 2022-08-24 (Crawled : 10:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M twitter stocktwits trandingview |
Health Technology
 | | O: -0.1% H: 0.25% C: -0.43%
VRNA | $15.21 -2.44% -2.5% 320K twitter stocktwits trandingview |
Health Technology
 | | O: -0.48% H: 5.66% C: 3.16%
pharma commercialization
Epygenix Therapeutics Announces Appointment of Dr. Lorianne Masuoka as Chief Medical Officer
Published: 2022-05-23 (Crawled : 10:00) - biospace.com/
NKTR | News | $1.39 -2.11% -2.16% 960K twitter stocktwits trandingview |
Health Technology
 | | O: -2.01% H: 0.51% C: -8.46%
therapeutics
BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland
Published: 2022-05-17 (Crawled : 10:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
 | | O: 6.37% H: 2.76% C: 1.73%
switzerland
Addex Reports Q1 2022 Financial Results
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
ADXN | $18.74 -10.32% 12K twitter stocktwits trandingview |
Health Technology
 | | O: 0.78% H: 9.31% C: 7.1%
results
Addex to Present at the Swiss Biotech Day 2022
Published: 2022-04-28 (Crawled : 10:00) - biospace.com/
ADXN | $18.74 -10.32% 12K twitter stocktwits trandingview |
Health Technology
 | | O: 4.42% H: 2.75% C: 2.75%
day biotech
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services
BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services
MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.